HuGE Literature Finder
Records
1
-
30
| Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci. Journal of the National Cancer Institute 2022 Oct . DeVries Amber A, Dennis Joe, Tyrer Jonathan P, Peng Pei-Chen, Coetzee Simon G, Reyes Alberto L, Plummer Jasmine T, Davis Brian D, Chen Stephanie S, Dezem Felipe Segato, Aben Katja K H, Anton-Culver Hoda, Antonenkova Natalia N, Beckmann Matthias W, Beeghly-Fadiel Alicia, Berchuck Andrew, Bogdanova Natalia V, Bogdanova-Markov Nadja, Brenton James D, Butzow Ralf, Campbell Ian, Chang-Claude Jenny, Chenevix-Trench Georgia, Cook Linda S, DeFazio Anna, Doherty Jennifer A, Dörk Thilo, Eccles Diana M, Eliassen A Heather, Fasching Peter A, Fortner Renée T, Giles Graham G, Goode Ellen L, Goodman Marc T, Gronwald Jacek, , , Håkansson Niclas, Hildebrandt Michelle A T, Huff Chad, Huntsman David G, Jensen Allan, Kar Siddhartha, Karlan Beth Y, Khusnutdinova Elza K, Kiemeney Lambertus A, Kjaer Susanne K, Kupryjanczyk Jolanta, Labrie Marilyne, Lambrechts Diether, Le Nhu D, Lubi?ski Jan, May Taymaa, Menon Usha, Milne Roger L, Modugno Francesmary, Monteiro Alvaro N, Moysich Kirsten B, Odunsi Kunle, Olsson Håkan, Pearce Celeste L, Pejovic Tanja, Ramus Susan J, Riboli Elio, Riggan Marjorie J, Romieu Isabelle, Sandler Dale P, Schildkraut Joellen M, Setiawan V Wendy, Sieh Weiva, Song Honglin, Sutphen Rebecca, Terry Kathryn L, Thompson Pamela J, Titus Linda, Tworoger Shelley S, Van Nieuwenhuysen Els, Edwards Digna Velez, Webb Penelope M, Wentzensen Nicolas, Whittemore Alice S, Wolk Alicja, Wu Anna H, Ziogas Argyrios, Freedman Matthew L, Lawrenson Kate, Pharoah Paul D P, Easton Douglas F, Gayther Simon A, Jones Michelle |
| DNA methylation of the immediate upstream region of BRCA1 major transcription start sites is an independent favorable prognostic factor in patients with high-grade serous ovarian cancer. Gynecologic oncology 2022 Oct . Ebata Takahiro, Yamashita Satoshi, Takeshima Hideyuki, Yoshida Hiroshi, Kawata Yoshiko, Kino Nao, Yasugi Toshiharu, Terao Yasuhisa, Yonemori Kan, Kato Tomoyasu, Ushijima Toshika |
| Mutations in circulating tumor DNA detected in the postoperative period predict poor survival in patients with ovarian cancer. Biomedical journal 2022 Oct . Chao Angel, Chen Shu-Jen, Chen Hua-Chien, Tan Kien Thiam, Hsiao Wen, Jung Shih-Ming, Yang Lan-Yan, Huang Kuan-Gen, Chou Hung-Hsueh, Huang Huei-Jean, Chang Ting-Chang, Chao An-Shine, Lee Yun-Hsien, Wu Ren-Chin, Lai Chyong-Hu |
| The Toll-like Receptor 4 Polymorphism Asp299Gly Is Associated with an Increased Risk of Ovarian Cancer. Cells 2022 Oct 11 (19): . Kania Katarzyna D, Har??a Daria, Wilczy?ski Jacek R, Wilczy?ski Mi?osz, Jarych Dariusz, Malinowski Andrzej, Paradowska Edy |
| Analysis of rare disruptive germline mutations in 2,135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes. Annals of oncology : official journal of the European Society for Medical Oncology 2022 Sep . Loveday C, Garrett A, Law P, Hanks S, Poyastro-Pearson E, Adlard J W, Barwell J, Berg J, Brady A F, Brewer C, Chapman C, Cook J, Davidson R, Donaldson A, Douglas F, Greenhalgh L, Henderson A, Izatt L, Kumar A, Lalloo F, Miedzybrodzka Z, Morrison P J, Paterson J, Porteous M, Rogers M T, Walker L, , Eccles D, Evans D G, Snape K, Hanson H, Houlston R S, Turnbull |
| Identifying the BRCA1 c.-107A?>?T variant in Dutch patients with a tumor BRCA1 promoter hypermethylation. Familial cancer 2022 Sep . de Jong Vincent M T, Pruntel Roelof, Steenbruggen Tessa G, Bleeker Fonnet E, Nederlof Petra, Hogervorst Frans B L, Linn Sabine |
| Mutational signature 3 detected from clinical panel sequencing is associated with responses to olaparib in breast and ovarian cancers. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 Sep . Batalini Felipe, Gulhan Doga C, Mao Victor, Tran Antuan, Polak Madeline, Xiong Niya, Tayob Nabihah, Tung Nadine M, Winer Eric P, Mayer Erica L, Knappskog Stian, Lønning Per Eystein, Matulonis Ursula A, Konstantinopoulos Panagiotis A, Solit David B, Won Helen, Eikesdal Hans Petter, Park Peter J, Wulf Gerburg |
| BRCA1/2 variants and copy number alterations status in non familial triple negative breast cancer and high grade serous ovarian cancer. Hereditary cancer in clinical practice 2022 Aug 20 (1): 29. El Ansari Fatima Zahra, Jouali Farah, Fekkak Rim, Bakkach Joaira, Ghailani Nourouti Naima, Barakat Amina, Bennani Mechita Mohcine, Fekkak Jam |
| Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients. BMC cancer 2022 Aug 22 (1): 842. Zhang Yunuo, Wu Heming, Yu Zhikang, Li Liang, Zhang Jinhong, Liang Xinhong, Huang Qingy |
| Platinum Resistance After PARPi Resistance in a gBRCAmt Recurrent Ovarian Cancer Patient: a Case Report. Reproductive sciences (Thousand Oaks, Calif.) 2022 Aug . Zhao Qian, Ni Jing, Dong Jiayin, Cheng Xianzhong, Xiao Li, Xue Qi, Xu Xia, Guo Wenwen, Chen Xiaoxia |
| A comprehensive literature review and meta-analysis of the prevalence of pan-cancer BRCA mutations, homologous recombination repair gene mutations, and homologous recombination deficiencies. Environmental and molecular mutagenesis 2022 Jul 63 (6): 308-316. Shao Changxia, Wan Jun, Lam Fred C, Tang Huilin, Marley Andrew R, Song Yiqing, Miller Chelsey, Brown Madeline, Han Jiali, Adeboyeje Gboye |
| Causal effects of genetically determined metabolites on cancers included lung, breast, ovarian cancer, and glioma: a Mendelian randomization study. Translational lung cancer research 2022 Jul 11 (7): 1302-1314. Feng Yi, Wang Runchen, Li Caichen, Cai Xiuyu, Huo Zhenyu, Liu Ziyu, Ge Fan, Huang Chuiguo, Lu Yi, Zhong Ran, Li Jianfu, Cheng Bo, Liang Hengrui, Xiong Shan, Mao Xingyu, Chen Yilin, Lan Ruying, Wen Yaokai, Peng Haoxin, Jiang Yu, Su Zixuan, Wu Xiangrong, He Jianxing, Liang Wenh |
| Effect of BRCA1/2 Mutational Status on Survival Outcomes According to Secondary Cytoreductive Surgery and Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer: A Real-World Evidence Study. Cancer research and treatment 2022 Jul . Kim Se Ik, Lim Hyunji, Kim Hee Seung, Chung Hyun Hoon, Kim Jae-Weon, Park Noh Hyun, Song Yong-Sang, Lee Mar |
| Epithelial Ovarian Cancer: Providing Evidence of Predisposition Genes. International journal of environmental research and public health 2022 Jul 19 (13): . Shah Sidrah, Cheung Alison, Kutka Mikolaj, Sheriff Matin, Boussios Stergi |
| Prevalence of FANCM germline variants in BRCA1/2 negative breast and/or ovarian cancer patients from Pakistan. Familial cancer 2022 Jul . Rashid Muhammad Usman, Muhammad Noor, Shehzad Umara, Khan Faiz Ali, Loya Asif, Hamann U |
| Minigene Splicing Assays Identify 20 Spliceogenic Variants of the Breast/Ovarian Cancer Susceptibility Gene Cancers 2022 Jun 14 (12): . Sanoguera-Miralles Lara, Bueno-Martínez Elena, Valenzuela-Palomo Alberto, Esteban-Sánchez Ada, Llinares-Burguet Inés, Pérez-Segura Pedro, García-Álvarez Alicia, de la Hoya Miguel, Velasco-Sampedro Eladio |
| Polygenic risk scores indicate extreme ages at onset of breast cancer in female BRCA1/2 pathogenic variant carriers. BMC cancer 2022 Jun 22 (1): 706. Borde Julika, Laitman Yael, Blümcke Britta, Niederacher Dieter, Weber-Lassalle Konstantin, Sutter Christian, Rump Andreas, Arnold Norbert, Wang-Gohrke Shan, Horváth Judit, Gehrig Andrea, Schmidt Gunnar, Dutrannoy Véronique, Ramser Juliane, Hentschel Julia, Meindl Alfons, Schroeder Christopher, Wappenschmidt Barbara, Engel Christoph, Kuchenbaecker Karoline, Schmutzler Rita K, Friedman Eitan, Hahnen Eric, Ernst Corin |
| Personalised Risk Prediction in Hereditary Breast and Ovarian Cancer: A Protocol for a Multi-Centre Randomised Controlled Trial. Cancers 2022 May 14 (11): . Archer Stephanie, Fennell Nichola, Colvin Ellen, Laquindanum Rozelle, Mills Meredith, Dennis Romy, Stutzin Donoso Francisca, Gold Rochelle, Fan Alice, Downes Kate, Ford James, Antoniou Antonis C, Kurian Allison W, Evans D Gareth, Tischkowitz Ma |
| Association between XRCC3 rs861539 Polymorphism and the Risk of Ovarian Cancer: Meta-Analysis and Trial Sequential Analysis. BioMed research international 2022 2022 3915402. Hu Siya, Jing Yunnan, Liu Fangyuan, Han Fengju |
| Clinical characteristics of patients with Breast and / or Ovarian Cancer with mutations in the BRCA1 and BRCA2 genes in Córdoba, Argentina Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) 2022 09 79 (3): 228-234. Martin Claudia Alejandra, Suárez Villasmil Lourdes, Sembaj Adela, Gomez Balangione Fabian, Zunino Silvia, Montes Cecilia Del Carmen, Borello Adriana, Del Castillo Andres, Zeballos Maximiliano, Rossi Norma Tere |
| Comparative Efficacy and Safety of Poly (ADP-Ribose) Polymerase Inhibitors in Patients With Ovarian Cancer: A Systematic Review and Network Meta-Analysis. Frontiers in oncology 2022 12 815265. Luo Jing, Ou Shunlong, Wei Hua, Qin Xiaoli, Jiang Qi |
| Evaluation of the Role of the KRAS Gene Polymorphism LCS6 (rs61764370) in Iraqi Women with Ovarian Cancer. Archives of Razi Institute 2022 02 77 (1): 205-211. Ghazi Jumaa |
| Genetic Polymorphism of E2F1 Influences Susceptibility to Ovarian Cancer in a Chinese Population. Contrast media & molecular imaging 2022 2022 7808726. Wu Yueyuan, You Zhiqun, Xu Mind |
| Genetic Variation of PD-L1 Gene Affects its Expression and Is Related to Clinical Outcome in Epithelial Ovarian Cancer. Frontiers in oncology 2022 12 763134. Sun Haiyan, Li Yan, Si Wengang, Hua Tian, Chen Juan, Kang Sh |
| Multi-gene panel testing increases germline predisposing mutations' detection in a cohort of breast/ovarian cancer patients from Southern Italy. Frontiers in medicine 2022 9 894358. Nunziato Marcella, Di Maggio Federica, Pensabene Matilde, Esposito Maria Valeria, Starnone Flavio, De Angelis Carmine, Calabrese Alessandra, D'Aiuto Massimiliano, Botti Gerardo, De Placido Sabino, D'Argenio Valeria, Salvatore Frances |
| Prevalence and Factors Associated with BRCA1/2 Gene Mutation in Chinese Populations with Breast Cancer. International journal of general medicine 2022 15 6783-6789. Huang Guoding, Lu Hongquan, Chen Qizhu, Huang Xinti |
| Progression-free survival and overall survival after BRCA1/2-associated epithelial ovarian cancer: A matched cohort study. PloS one 2022 17 (9): e0275015. Heemskerk-Gerritsen Bernadette A M, Hollestelle Antoinette, van Asperen Christi J, van den Beek Irma, van Driel Willemien J, van Engelen Klaartje, Gómez Garcia Encarna B, de Hullu Joanne A, Koudijs Marco J, Mourits Marian J E, Hooning Maartje J, Boere Ingrid |
| PROM1, CXCL8, RUNX1, NAV1 and TP73 genes as independent markers predictive of prognosis or response to treatment in two cohorts of high-grade serous ovarian cancer patients. PloS one 2022 17 (7): e0271539. Dansonka-Mieszkowska Agnieszka, Szafron Laura Aleksandra, Kulesza Magdalena, Stachurska Anna, Leszczynski Pawel, Tomczyk-Szatkowska Agnieszka, Sobiczewski Piotr, Parada Joanna, Kulinczak Mariusz, Moes-Sosnowska Joanna, Pienkowska-Grela Barbara, Kupryjanczyk Jolanta, Chechlinska Magdalena, Szafron Lukasz Mich |
| Whole-genome/exome analysis of circulating tumor DNA and comparison to tumor genomics from patients with heavily pre-treated ovarian cancer: subset analysis of the PERMED-01 trial. Frontiers in oncology 2022 12 946257. Sabatier Renaud, Garnier Séverine, Guille Arnaud, Carbuccia Nadine, Pakradouni Jihane, Adelaide José, Provansal Magali, Cappiello Maria, Rousseau Frédérique, Chaffanet Max, Birnbaum Daniel, Mamessier Emilie, Gonçalves Anthony, Bertucci Franço |
| Pleiotropic Neuro-oncology advances 0 4 (1): vdac044. Walsh Kyle M, Zhang Chenan, Calvocoressi Lisa, Hansen Helen M, Berchuck Andrew, Schildkraut Joellen M, Bondy Melissa L, Wrensch Margaret, Wiemels Joseph L, Claus Elizabeth |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 03, 2023
- Content source: